NEFL and amyotrophic lateral sclerosis: We and others conducted a similar study investigating serum NFL in ALS patients (n = 124), patients with other neurodegenerative diseases, patients with conditions in the differential diagnosis of ALS, and neurological patients without neurodegenerative diseases.